The FY2024 (Dec) proxy of Wave Life Sciences names 15 peer companies for pay. Among Wave Life Sciences and these peers, CEO pay was the lowest of 7 and total shareholder return was the highest of 7.
7th highest of 7in Wave Life Sciences and its pay peers, FY2024 (Dec) by CEO pay:
$4.3M$15.4M
1st highest of 7in Wave Life Sciences and its pay peers, FY2024 (Dec) by total shareholder return:
$58$157
Pay peer group, FY2024 (Dec) proxy
| Ionis Pharmaceuticals | ||
| Intellia Therapeutics | ||
| PTC Therapeutics | ||
| Denali Therapeutics | ||
| Beam Therapeutics | ||
| Stoke Therapeutics | ||
| Alector, Inc. | Not disclosed | Not disclosed |
| Arcturus Therapeutics Holdings, Inc. | Not disclosed | Not disclosed |
| Arrowhead Pharmaceuticals | Not disclosed | Not disclosed |
| Avidity Biosciences, Inc. | Not disclosed | Not disclosed |
| Dyne Therapeutics | Not disclosed | Not disclosed |
| Editas Medicine, Inc. | Not disclosed | Not disclosed |
| Prime Medicine, Inc. | Not disclosed | Not disclosed |
| Sangamo Therapeutics | Not disclosed | Not disclosed |
| Verve Therapeutics, Inc. | Not disclosed | Not disclosed |
15 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.